All health is not equal: the use of modifiers in NICE technology appraisal
- 27 January 2023
- journal article
- research article
- Published by BMJ in BMJ Evidence-Based Medicine
- Vol. 28 (4) , 247-250
Abstract
Nineteen years on, NICE has maintained its reputation as an innovator, and its methods have evolved considerably.2 3 One change concerns its adoption of numerical ‘modifiers’ to adjust how the health needs of different groups are prioritised in evaluating new technologies. This article describes NICE’s current modifiers and briefly considers the implications of their use.Keywords
Funding Information
- Wellcome Trust (203351/Z/16/Z)
This publication has 8 references indexed in Scilit:
- NICE’s new methods: putting innovation first, but at what cost?BMJ, 2022
- How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13Applied Health Economics and Health Policy, 2021
- Estimating Social Variation in the Health Effects of Changes in Health Care ExpenditureMedical Decision Making, 2020
- NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence, 1999–2018Health Care Analysis, 2019
- NICE's end of life decision making scheme: impact on population healthBMJ, 2013
- National Institute for Clinical Excellence and its value judgmentsBMJ, 2004
- The triumph of NICEBMJ, 2004
- NICE: faster access to modern treatments? Analysis of guidance on health technologiesBMJ, 2001